The ONLY FDA-cleared, CLIA-waived test that delivers both HIV 1/2 and Treponema pallidum results from a single sample at the point of care.
Replace two separate rapid tests with one integrated solution that delivers independent HIV-1/2 and T. pallidum antibody results from a single specimen. Simplify your workflow, reduce testing complexity, and support timely clinical decision-making—all without compromising the clinical information providers rely on.
Dual Detection
Detects HIV and T. pallidum in a single test from one sample
Proven Performance
>99% HIV 1/2 and
>94% T. pallidum sensitivity*
*fingerstick whole blood
Simplified Workflow
1 Sample.
1 Testing Procedure.
2 Independent Results.
Objective Results
DPP® Micro Reader provides objective digital interpretation for consistent results.
Test in 3 Easy Steps
DPP® HIV-Syphilis Assay Video
(for Fingerstick Blood)
Frequently Asked Questions
Are there other confirmatory tests needed when using these rapids?
In the reverse testing algorithm for syphilis, you will need to reflex to RPR to find out if you have an active or past infection. For HIV you would need to confirm a positive based on your site’s protocols.
Could temperature be a factor when using this test in the field or on the street?
The test components should be at room temperature, 18 to 25° C (64 to 77° F), before performing the test and the test should be performed within the same temperature range. If the temperature of the testing area falls outside of 18 to 25° C (64 to 77° F) it is recommended to perform QC prior to testing.
Is it possible to visually interpret the test?
No. The test must be read using the DPP Micro Reader.
Is there any data regarding efficacy with pregnant patients?
Yes. The Instructions for Use (IFU) include performance data for use in pregnant patients. To obtain a copy of the IFU, please complete the Contact Us form on this website. Our team will review your request and provide the appropriate documentation.
Is this a 4th Generation HIV test?
No. Chembio rapid HIV tests detect antibodies to HIV-1 and HIV-2 and do not detect HIV-1 p24 antigen.
Rapid antibody tests are an established option for point-of-care HIV testing, providing accurate, CLIA-waived results from fingerstick whole blood in settings where immediate results are needed. Laboratory fourth-generation HIV assays are designed to detect both HIV-1 p24 antigen and HIV-1/2 antibodies and may identify infection earlier than antibody-only tests. Published studies have reported that current rapid fourth-generation point-of-care assays have limited sensitivity for detecting acute HIV infection because of the brief period during which free p24 antigen is detectable.
Healthcare providers should follow current CDC HIV testing recommendations and use the testing method that best meets the clinical needs of their patients.
References
- Centers for Disease Control and Prevention (CDC). HIV Testing. Updated guidance on recommended HIV testing algorithms and technologies.
- Lewis JM, Macpherson P, Adams ER, et al. Field accuracy of fourth-generation rapid diagnostic tests for acute HIV-1: a systematic review. AIDS. 2015;29(18):2465-2471.
What is the shelf-life?
24 months from date of manufacture
What is the product performance?
| Parameter* | HIV** | Treponema pallidum** |
| Sensitivity | 99.4% | 94.7% |
| Specificity | 99.6% | 95.5% |
* Refer to product insert for details
** For fingerstick whole blood
| Information Type | Product Detail | |
| Method | Dual Path Platform | |
| Time to Results | 15 minutes | |
| Test & External Controls Shelf Life | 24 months | |
| Storage Conditions | 2 to 25°C (36 to 77°F) | |
| CPT Codes | 86703; 86780 More Reimbursement Info |
|
Ordering Information
| Product | Catalog Number |
| DPP® HIV-Syphilis (20 tests) FDA Approved | 65-9502-0 |
| DPP® HIV-Syphilis Rapid Test Control Pack | 60-9555-0 |
| DPP® Micro Reader for Use with DPP® HIV-Syphilis | 70-1056-0 |
See how this product can support your testing program.
Connect with a sales representative to discuss your needs, product fit, and next steps.
